透過您的圖書館登入
IP:3.145.60.166
  • 期刊

以OK-432囊內注射治療頸部淋巴管瘤

Treatment of Cervical Lymphangioma with Intracystic Injection of OK-432

摘要


淋巴管瘤(lymphangioma)常見於兩歲以下的幼兒身上,尤其好發於頭頸部,通常以手術切除爲主,但常因腫瘤太大或侵犯到附近的重要器官或構造,而無法將腫瘤完全切除,腫瘤復發的機率也高,所以就有人提出非手術切除的代替性療法。近來有文獻指出,以OK-432囊內注射來治療頭頸部的淋巴管瘤,是十分安全且具有高度療效的治療方式,所以當5歲半大男孩因突發性右臉腫賬來就診,經由病史、理學檢查、影像學診斷,以及針吸式活組織檢驗確定診斷爲淋巴管瘤,且研判手術無法將腫瘤完全切除後,決定在全身麻醉下使用OK-432注射於腫瘤內,注射後以磁振造影追蹤,發現腫瘤完全消失且無明顯併發症,至今亦無復發的情形,特提出報告。

關鍵字

淋巴管瘤 OK-432

並列摘要


Lymphangioma typically appears in children younger than 2 years, and the head and neck is the most frequently affected site. Complete excision is currently the treatment of choice, but this goal is sometimes difficult to achieve due to large tumor size and invasion to surrounding vital organ or structure with high recurrence rate. Therefore, non-surgical alternative treatment had been attempted. In recent paper review, intracystic injection of OK-432 into the lymphangioma had reported marked regression with acceptable safety and effectiveness. When this five-year-old patient was diagnosed with lymphangioma by a series of examination, we decided to perform intracystic injection of OK-432 under general anesthesia. In the postoperative follow-up with MRI, we found that treatment outcome was good. No obvious complications or tumor recurrence was noted until now.

並列關鍵字

lymphangioma OK-432

延伸閱讀